M&T Bank Corporation vs 10X Genomics Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: M&T Bank Corporation is far larger — about 6.6× 10X Genomics Inc's market cap, and M&T Bank Corporation pays a 2.41% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| MTB | TXG | |
|---|---|---|
Market Cap | $36.15B | $5.48B |
Sector | Financials | Health |
52-Week High | $254.04 | $45.80 |
52-Week Low | $178.63 | $11.34 |
Dividend Yield | 2.41% | — |
Enterprise Value | — | $5.02B |
Trailing returns across standard periods
Latest headlines on both assets
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →